Skip to main content

abrdn Healthcare Investors

HQH
Exchange
NYSE
SEC CIK
0000805267

In the last 90 days, abrdn Healthcare Investors insiders filed 1 open-market purchase and 0 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $293.0M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by abrdn Healthcare Investors insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $10.5K in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$10.5K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for abrdn Healthcare Investors, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for abrdn Healthcare Investors
NameTitleLast reported holdingLast filingFilings, past year
Mahai Chris LaVictoireDirector501Jul 20, 20261
DiMartino RoseDirector1,000Jul 18, 20240
Goetz KathleenDirector1,080Apr 12, 20240
Goodson Alan RVice President170Jan 9, 20240
Reit ToddDirector1,000Jan 4, 20240
Maher BillDirector1,000Jan 2, 20240
Omstead Daniel RPresident178,269Sep 25, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 20, 2026 (view filing)2:34 PM ETJul 164 daysMahai Chris LaVictoireDirectorPPurchase+501$20.96+$10.5KNew position501 after
Jul 18, 2024 (view filing)Jul 162 daysDiMartino RoseDirectorPPurchase+1.00K$18.88+$18.9KNew position1.00K after
Apr 12, 2024 (view filing)Apr 93 daysLateGoetz KathleenDirectorPPurchase+525$16.42+$8.62K+94.7%1.08K after
Jan 9, 2024 (view filing)Dec 21, 202319 daysLateGoodson Alan RVice PresidentPPurchase+170$16.13+$2.74KNew position170 after
Jan 4, 2024 (view filing)Jan 22 daysReit ToddDirectorPPurchase+1.00K$16.93+$16.9KNew position1.00K after
Jan 2, 2024 (view filing)Dec 28, 20235 daysMaher BillDirectorPPurchase+1.00K$16.58+$16.6KNew position1.00K after
Sep 25, 2023 (view filing)Sep 25Same dayOmstead Daniel RPresidentPPurchaseShares of Beneficial Interest+9.50K$15.63+$148.5K+5.6%178.3K after
Sep 20, 2023 (view filing)Sep 20Same dayOmstead Daniel RPresidentPPurchaseShares of Beneficial Interest+9.50K$15.88+$150.9K+6.0%168.8K after
Mar 24, 2022 (view filing)Mar 231 dayGoetz KathleenDirectorPPurchaseShares of Beneficial Interest+73.53$20.42+$1.50K+15.3%554.53 after
Jan 27, 2022 (view filing)Jan 261 dayGoetz KathleenDirectorPPurchaseShares of Beneficial Interest+481$21.52+$10.4KNew position481 after